BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27880939)

  • 1. Inhibition of the transcriptional repressor complex Bcl-6/BCoR induces endothelial sprouting but does not promote tumor growth.
    Buchberger E; Payrhuber D; El Harchi M; Zagrapan B; Scheuba K; Zommer A; Bugyik E; Dome B; Kral JB; Schrottmaier WC; Schabbauer G; Petzelbauer P; Gröger M; Bilban M; Brostjan C
    Oncotarget; 2017 Jan; 8(1):552-564. PubMed ID: 27880939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene of the month: BCOR.
    Aldera AP; Govender D
    J Clin Pathol; 2020 Jun; 73(6):314-317. PubMed ID: 32161069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the transcriptional repressor complex BCL-6/BCoR leads to nuclear aggregates distinct from classical aggresomes.
    Buchberger E; El Harchi M; Payrhuber D; Zommer A; Schauer D; Simonitsch-Klupp I; Bilban M; Brostjan C
    PLoS One; 2013; 8(10):e76845. PubMed ID: 24146931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin cytoplasmic domain-associated protein-1 attenuates sprouting angiogenesis.
    Brütsch R; Liebler SS; Wüstehube J; Bartol A; Herberich SE; Adam MG; Telzerow A; Augustin HG; Fischer A
    Circ Res; 2010 Sep; 107(5):592-601. PubMed ID: 20616313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
    Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
    Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial Jagged1 antagonizes Dll4 regulation of endothelial branching and promotes vascular maturation downstream of Dll4/Notch1.
    Pedrosa AR; Trindade A; Fernandes AC; Carvalho C; Gigante J; Tavares AT; Diéguez-Hurtado R; Yagita H; Adams RH; Duarte A
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1134-46. PubMed ID: 25767274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells.
    Polo JM; Dell'Oso T; Ranuncolo SM; Cerchietti L; Beck D; Da Silva GF; Prive GG; Licht JD; Melnick A
    Nat Med; 2004 Dec; 10(12):1329-35. PubMed ID: 15531890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.
    Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL
    Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta-like 4/Notch signaling promotes Apc
    Badenes M; Trindade A; Pissarra H; Lopes-da-Costa L; Duarte A
    BMC Cancer; 2017 Jan; 17(1):50. PubMed ID: 28086833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of DLL4 siRNA on proliferation, migration and tube formation of choroid-retinal endothelial cells under hypoxic conditions.
    He H; Li B; Zhang H; Xiang N; Li GG
    Chin Med J (Engl); 2011 Jan; 124(1):118-26. PubMed ID: 21362319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of a BCOR corepressor peptide in complex with the BCL6 BTB domain dimer.
    Ghetu AF; Corcoran CM; Cerchietti L; Bardwell VJ; Melnick A; Privé GG
    Mol Cell; 2008 Feb; 29(3):384-91. PubMed ID: 18280243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets.
    Gearhart MD; Corcoran CM; Wamstad JA; Bardwell VJ
    Mol Cell Biol; 2006 Sep; 26(18):6880-9. PubMed ID: 16943429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Critical Role of miR-144 in Diffuse Large B-cell Lymphoma Proliferation and Invasion.
    Wang H; Wang A; Hu Z; Xu X; Liu Z; Wang Z
    Cancer Immunol Res; 2016 Apr; 4(4):337-44. PubMed ID: 26865454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions.
    Pedrosa AR; Trindade A; Carvalho C; Graça J; Carvalho S; Peleteiro MC; Adams RH; Duarte A
    Oncotarget; 2015 Sep; 6(27):24404-23. PubMed ID: 26213336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch pathway targets proangiogenic regulator Sox17 to restrict angiogenesis.
    Lee SH; Lee S; Yang H; Song S; Kim K; Saunders TL; Yoon JK; Koh GY; Kim I
    Circ Res; 2014 Jul; 115(2):215-26. PubMed ID: 24755984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate.
    Diez H; Fischer A; Winkler A; Hu CJ; Hatzopoulos AK; Breier G; Gessler M
    Exp Cell Res; 2007 Jan; 313(1):1-9. PubMed ID: 17045587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mad1 is a transcriptional repressor of Bcl-6.
    Lee SC; Bottaro A; Chen L; Insel RA
    Mol Immunol; 2006 May; 43(12):1965-71. PubMed ID: 16423395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis.
    Adam MG; Berger C; Feldner A; Yang WJ; Wüstehube-Lausch J; Herberich SE; Pinder M; Gesierich S; Hammes HP; Augustin HG; Fischer A
    Circ Res; 2013 Nov; 113(11):1206-18. PubMed ID: 24025447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-protein coupled receptor 124 (GPR124) in endothelial cells regulates vascular endothelial growth factor (VEGF)-induced tumor angiogenesis.
    Wang Y; Cho SG; Wu X; Siwko S; Liu M
    Curr Mol Med; 2014 May; 14(4):543-54. PubMed ID: 24730523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tumor angiogenesis and tumor growth by the DSL domain of human Delta-like 1 targeted to vascular endothelial cells.
    Zhao XC; Dou GR; Wang L; Liang L; Tian DM; Cao XL; Qin HY; Wang CM; Zhang P; Han H
    Neoplasia; 2013 Jul; 15(7):815-25. PubMed ID: 23814493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.